Mannatech Inc (MTEX) · Oct 14, 2026 · Delisting
Listing compliance update — Equity was $(4.97M) versus a $2.5M Nasdaq minimum; pro forma cure not quantified
Mannatech’s Nasdaq compliance filing points to a Swiss tax restructuring that could repair negative equity, but auditor and Nasdaq approval remain outstanding.
Mannatech is a global wellness-products company operating largely through direct selling, while dealing with a pressured revenue environment and already-negative equity. Its 2025 sales fell amid broader direct-selling industry pressures, making this a balance-sheet and listing-survival issue rather than a growth announcement.
The filing offers a possible technical fix, not a confirmed recovery. Nasdaq requires at least $2.5 million of stockholders’ equity, while Mannatech reported $(5.223) million at December 31, 2025 and $(4.970) million at June 30, 2026. (Nasdaq compliance disclosure) 〔0〕
| Measure | Amount |
|---|---|
| Nasdaq minimum stockholders’ equity | $2.500M (Nasdaq listing requirement) |
| Reported equity at December 31, 2025 | $(5.223)M (10-K) |
| Reported equity at June 30, 2026 | $(4.970)M (10-Q) |
| Pro forma equity after tax reassessment | Not disclosed |
The Swiss transaction could materially reduce the tax liability embedded in equity. Mannatech acquired 100% direct ownership of Swiss Holdings, replacing indirect ownership through Gibraltar, and says Swiss distributions may qualify for a 5% withholding-tax rate. That reassessment could lift reported equity by lowering the deferred tax liability, but the filing does not disclose the resulting pro forma equity or show that the roughly $7.5 million shortfall to Nasdaq has been eliminated.
The compliance status remains provisional. Management says it believes the reassessment restores compliance, but the calculation still requires independent-accountant review, and Nasdaq has not concurred. The next meaningful proof point is the Q3 10-Q, which Mannatech expects to file by November 16, 2026. 〔1〕
Bottom line: This is a credible attempt to solve Mannatech’s Nasdaq problem through a tax-accounting change, but it does not yet establish compliance. The business story is largely unchanged; the immediate issue is whether auditors and Nasdaq accept the proposed equity uplift before the next listing review.
Q3 10-Q and auditor review, due by November 16
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!